oxb

Showing 1 posts of 1 posts found.

Novartis signs $90m deal with Oxford BioMedica

October 10, 2014
Manufacturing and Production, Research and Development, Sales and Marketing CART-019, Novartis, Oxford BioMedica, immunotherapy, oxb

UK-based biotech Oxford BioMedica is working with Novartis in a transformational deal for the firm worth $90 million to develop …

The Gateway to Local Adoption Series

Latest content